The board of directors of Baxter International Inc. (NYSE:BAX) authorised a quarterly dividend of USD0.28 per share of its common stock, the company declared on Tuesday.
This cash dividend is due on 3 January 2022 to shareholders of record as of 3 December 2021.
Annually, the dividend rate is equivalent to USD1.12 per share of the company's common stock.
Baxter is a medical products company that provides a portfolio of critical care, nutrition, renal, hospital and surgical products, products, technologies and therapies in more than 100 countries.
Eli Lilly announces Q1 2026 dividend
Amgen announces Q4 2025 dividend
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government